Effect of promoters and enhancers on expression, transgene DNA persistence, and hepatotoxicity after adenoviral gene transfer of human apolipoprotein A-I

Human Gene Therapy

Volumn 13, Issue 7, 2002, Pages 829-840

  Van Linthout, Sophie ^a   Collen, Désiré ^a   De Geest, Bart ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN C2; APOLIPOPROTEIN E; DNA; NUCLEAR RNA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ENHANCER REGION; GENE CASSETTE; GENE EXPRESSION; GENE INDUCTION; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC ANALYSIS; LIVER TOXICITY; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN BLOOD LEVEL; RNA ANALYSIS; TRANSGENE;

ADENOVIRIDAE; ANIMALS; APOLIPOPROTEIN A-I; AREA UNDER CURVE; CHROMATOGRAPHY, GEL; DNA; ENHANCER ELEMENTS (GENETICS); ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; KINETICS; LIPID METABOLISM; LIVER; MICE; MICE, INBRED C57BL; PROMOTER REGIONS (GENETICS); TIME FACTORS; TRANSGENES;

ADA; ADENOVIRIDAE; ANIMALIA; MURINAE;

EID: 0036252993     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340252899000     Document Type: Article

References (36)

1. Efficient expression of protein coding genes from the murine U1 small nuclear RNA promoters
2. Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo
3. Regulatory squelching
4. Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products
5. The human U1 snRNA promoter and enhancer do not direct synthesis of messenger RNA
6. Effects of adenovirus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo E-deficient mice
7. Sustained expression of human apolipoprotein A-I following adenoviral gene transfer in C57BL/6 mice. Role of apo A-I promoter, apo A-I introns and human apo E enhancer
8. Sustained expression of human apo A-I in mice
9. Biology of ade-novirus vectors with E1 and E4 deletions for liver-directed gene therapy
10. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies
11. Quantitative evaluation of liver-specific promoters from retroviral vectors after in vivo transduction of hepatocytes
12. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo
13. In vitro and in vivo biology of recombinant adenovirus vectors with E1,E1/E2A, or E1/E4 deleted
14. Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: Requirement for E4 ORF3
15. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5
16. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro
17. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy
18. High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity
19. Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication
20. Liver-directed gene therapy: A retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo
21. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice
22. The human alpha 1-antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes
23. Evaluation of relative promoter strength in primary hepatocytes using optimized lipofection
24. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse
25. Evaluation of abnormal liver-enzyme results in asymptomatic patients
26. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
27. Localization of a liver-specific enhancer in the apolipoprotein E/C-I/C-II gene locus
28. A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice
29. Generation of adenovirus vectors devoid of all viral genes by recombination between inverted repeats
30. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo
31. Liver-directed gene therapy: Prospects and problems
32. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice
33. A short proximal promoter and the distal hepatic control region-1 (HCR-1) contribute to the liver specificity of the human apolipoprotein C-II gene. Hepatic enhancement by HCR-1 requires two proximal hormone response elements which have different binding specificities for orphan receptors HNF-4, ARP-1, and EAR-2
34. The structure of the human apolipoprotein C-II gene. Electron microscopic analysis of RNA:DNA hybrids, complete nucleotide sequence, and identification of 5′ homologous sequences among apolipoprotein genes
35. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo
36. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo